These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14712548)

  • 61. Learning to lead at Toyota.
    Spear SJ
    Harv Bus Rev; 2004 May; 82(5):78-86, 151. PubMed ID: 15146738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Informal networks: the company behind the chart.
    Krackhardt D; Hanson JR
    Harv Bus Rev; 1993; 71(4):104-11. PubMed ID: 10127036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. To succeed in the long-term, focus on the middle-term.
    Moore GA
    Harv Bus Rev; 2007; 85(7-8):84-90, 192. PubMed ID: 17642127
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
    Levin M
    Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The lean service machine.
    Swank CK
    Harv Bus Rev; 2003 Oct; 81(10):123-9, 138. PubMed ID: 14521103
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The leadership team: complementary strengths or conflicting agendas?
    Miles SA; Watkins MD
    Harv Bus Rev; 2007 Apr; 85(4):90-8, 141. PubMed ID: 17432156
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Break through to 98 percent inventory record integrity in just 120 days.
    Ribar TF
    Hosp Mater Manage Q; 1998 Nov; 20(2):15-21. PubMed ID: 10339174
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The peopleware paradigm.
    Andrew CG
    Hosp Mater Manage Q; 1996 Aug; 18(1):47-60. PubMed ID: 10159799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Creativity: the key to breakthrough changes, how teaming can harness collective knowledge.
    Helle PF
    Hosp Mater Manage Q; 1999 Aug; 21(1):7-12. PubMed ID: 10662453
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Value acceleration: lessons from private-equity masters.
    Rogers P; Holland T; Haas D
    Harv Bus Rev; 2002 Jun; 80(6):94-101, 153. PubMed ID: 12048998
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Toward a theory of high performance.
    Kirby J
    Harv Bus Rev; 2005; 83(7):30-9, 190. PubMed ID: 16028814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reshaping an industry: Lockheed Martin's survival story.
    Augustine NR
    Harv Bus Rev; 1997; 75(3):83-94. PubMed ID: 10167598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The turnaround value of values.
    Thorbeck J
    Harv Bus Rev; 1991; 69(1):52-4, 56-8, 60-2. PubMed ID: 10109472
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How CEOs manage growth agendas.
    Freeman KW; Nolen G; Tyson J; Lewis KD; Greifeld R; Gulati R
    Harv Bus Rev; 2004; 82(7-8):124-32, 189. PubMed ID: 15241959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. When failure isn't an option.
    Hillmann MR; Dongier P; Murgallis RP; Khosh M; Allen EK; Evernham R
    Harv Bus Rev; 2005; 83(7):41-6, 48-50, 190. PubMed ID: 16028815
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Turning great strategy into great performance.
    Mankins MC; Steele R
    Harv Bus Rev; 2005; 83(7):64-72, 191. PubMed ID: 16028817
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beyond governance reform: the road to exceptional governance.
    Totten MK
    Trustee; 2007 Apr; 60(4):30-1. PubMed ID: 17491191
    [No Abstract]   [Full Text] [Related]  

  • 78. Restructuring the total quality way--corporate quality leaders share their experiences. Interview by Lisa M. O'Rourke.
    Andreatis N; Arendt C
    Qual Lett Healthc Lead; 1994 Feb; 6(1):13-7. PubMed ID: 10132209
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The virtue matrix. Calculating the return on corporate responsibility.
    Martin RL
    Harv Bus Rev; 2002 Mar; 80(3):68-75, 132. PubMed ID: 11894384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The unexpected benefits of Sarbanes-Oxley.
    Wagner S; Dittmar L
    Harv Bus Rev; 2006 Apr; 84(4):133-40; 150. PubMed ID: 16579420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.